USE OF THE HORMONAL RESPONSE TO CLOMIPHENE CITRATE AS AN ENDOCRINOLOGIC INDICATOR OF OVARIAN AGING

被引:12
作者
NADER, S
BERKOWITZ, AS
机构
[1] Department of Obstetrics, Gynecology and Reproductive Sciences, University of Texas Medical School, #3.204 Houston, TX 77030, Houston
关键词
AGING; CLOMIPHENE CITRATE; GONADOTROPINS; OVARY;
D O I
10.1093/oxfordjournals.humrep.a137463
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
We compared the gonadotrophin and oestradiol responses to clomiphene citrate (CC) in women aged 18-25 versus 35-40 years. Despite similar baseline hormone concentrations and the attainment of similar concentrations of the E and Z isomers of clomiphene, higher follicle stimulating hormone (FSH) concentrations were observed in the older women, possibly indicative of their ageing ovaries. Furthermore, diminished oestradiol responses occurred in a subgroup of women showing FSH hyper-responsiveness to CC. These preliminary results support the concept that the hormonal response to CC may be an indicator of approaching perimenopause.
引用
收藏
页码:931 / 933
页数:3
相关论文
共 11 条
  • [1] Baustian C.L., Mikkelson T.J., Analysis of clomiphene isomers in human plasma and detection of metabolites using reversed- phase chromatography and fluorescence detection, J. Pharmaceut Biomed. Anal, 4, pp. 237-246, (1986)
  • [2] Bond D.J., Chandley A.C., Aneuploidx. Oxford University Press, London, pp. 62-69, (1983)
  • [3] Federation C., Schwartz D., Mayaux M.J., Female fecundity as a function of age, N. Engl. J. Med, 30, pp. 404-406, (1982)
  • [4] Dechemey A.H., Berkowitz G.S., Female fecundity and age, N. Engl. J. Med, 30, pp. 424-426, (1982)
  • [5] Feldberg D., Farhi J., Dicker D., Ashkenazi J., Shelef M., Goldman J.A., The Impact of Embryo Quality on Pregnancy Outcome in Elderly Women Undergoing IVF-ET. J. Vitro Fertil. Embryo Transfer, 7, pp. 257-261, (1990)
  • [6] Gosden R.G., Follicular status at the menopause. Hum, Reprod, 2, pp. 617-621, (1987)
  • [7] Jones G.S., Muasher S.J., Rosenwaks Z., Acosta A.A., Liv H.C., The perimenopausal patient in in vitro fertilization: The use of gonadotropin releasing hormone. Fertil, Steril, 46, pp. 885-891, (1986)
  • [8] Metcalf M.G., Donald R.A., Livesey J.H., Pituitary-ovarian function in normal women during the menopausal transition. Clin, Endocrinol, 14, pp. 245-255, (1981)
  • [9] Navot D., Rosenwaks Z., Margalioth E.J., Prognostic assessment of female fecundity, Lancet, Ii, pp. 645-647, (1987)
  • [10] Sherman B.M., Korenman S.G., Hormonal characteristics of the human menstrual cycle throughout reproductive life, J. Clin. Invest, 55, pp. 699-706, (1975)